Company BioLineRx Ltd.

Equities

BLRX

IL0011015182

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Ratings for BioLineRx Ltd.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 07:24:09 2024-04-25 EDT			5-day change	1st Jan Change
16.7 ^ILa	-0.60%		0.00%	-56.28%

04-17	BioLineRx Ltd. Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists Including APHEXDA® (Motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting	CI
04-10	BioLineRx Ltd. Accesses Second Tranche of $20 Million Under Previously Announced $40 Million Non-Dilutive Debt Financing Agreement	CI

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Number of employees: 79

ILS in Million	2022	Weight	2023	Weight	Delta
License 96.0 %	-	-	17	96.0 %	-
Oncology and Hematology 4.0 %	0	nan %	1	4.0 %	-

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	0	nan %	18	100.0 %	-

Managers	Title	Age	Since
Philip Serlin CEO	Chief Executive Officer	62	09-05-23
Mali Zeevi DFI	Director of Finance/CFO	48	08-12-31
Irit Gliko-Kabir CTO	Chief Tech/Sci/R&D Officer	-	17-08-31
John Lacey IRC	Investor Relations Contact	-	-
Asaf Aloni PRN	Corporate Officer/Principal	-	-
Tali Yaron Dalah AUD	Comptroller/Controller/Auditor	46	-
Ella Sorani PRN	Corporate Officer/Principal	56	17-01-31
Holly May PRN	Corporate Officer/Principal	-	22-06-15
Tsipi Keren-Lehrer PRN	Corporate Officer/Principal	-	19-07-31

Members of the board	Title	Age	Since
Sandra Panem BRD	Director/Board Member	77	14-02-23
Avraham Molcho BRD	Director/Board Member	66	09-12-31
Aharon Schwartz CHM	Chairman	80	03-12-31
Barbara-Jean Bormann-Kennedy BRD	Director/Board Member	65	13-08-18
Raf Hofstein BRD	Director/Board Member	74	02-12-31
Rami Dar BRD	Director/Board Member	67	22-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,199,089,165	1,194,817,450 ( 99.64 %)	0	99.64 %

Name	Equities	%	Valuation
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 9.427 %	102,437,055	9.427 %	8 M ILa
Aharon Schwartz 0.3410 %	3,705,000	0.3410 %	283 173 ILa
KSM Mutual Funds Ltd. 0.2412 %	2,620,703	0.2412 %	200 300 ILa
Migdal Mutual Funds Ltd. 0.0940 %	1,020,918	0.0940 %	78 029 ILa
Mali Zeevi 0.0302 %	328,665	0.0302 %	25 120 ILa
Dimensional Fund Advisors Ltd. 0.0278 %	302,259	0.0278 %	23 102 ILa
Philip Serlin 0.0158 %	171,900	0.0158 %	13 138 ILa
Ayalon Mutual Funds Ltd. 0.0122 %	133,041	0.0122 %	10 168 ILa
Ella Sorani 0.006088 %	66,150	0.006088 %	5 056 ILa
Ramco Mutual Funds Management (1989) Ltd. 0.002669 %	29,000	0.002669 %	2 216 ILa

Name	Equities	%	Valuation
Morgan Stanley Capital Services LLC 0.3289 %	238,261	0.3289 %	266 852 ILa
Values First Advisors, Inc. 0.2811 %	203,633	0.2811 %	228 069 ILa
Susquehanna Securities LLC 0.1795 %	129,994	0.1795 %	145 593 ILa
Western International Securities, Inc. 0.1524 %	110,366	0.1524 %	123 610 ILa
PVG Asset Management Corp. 0.0854 %	61,840	0.0854 %	69 261 ILa
RBC Dominion Securities, Inc. 0.0645 %	46,713	0.0645 %	52 319 ILa
Geneos Wealth Management, Inc. 0.0559 %	40,500	0.0559 %	45 360 ILa
Qube Research & Technologies Ltd. (France) 0.0558 %	40,435	0.0558 %	45 287 ILa
Geode Capital Management LLC 0.0552 %	39,993	0.0552 %	44 792 ILa
RATHBONES GROUP PLC 0.0550 %	39,820	0.0550 %	44 598 ILa

BioLineRx Ltd.

Modi'in Technology Park 2 HaMa'ayan Street

7177871, Modi'in

+972 8 642 9100

http://www.biolinerx.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
BIOLINERX LTD.	-56.28%	52.51M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs